"健康，是THE COLOR RUN与翡翠丝带共同的语言。"中心负责人张建敏希望通过这样一种轻松、愉悦 有益于肝脏代谢的健康奔跑方式，让更多人关注到肝脏健康的重要性，不要让乙肝拉远爱的距离。 校对 王心 封面图片/北大斯坦福亚裔肝脏中心 新京报讯（记者王卡拉）被誉为"地球上最快乐的5公里跑"的THE COLOR RUN彩色跑近日在北京园博 园开跑，近两万名跑者身着纯白T恤，在彩粉的海洋中尽情挥洒汗水与热情。作为活动多年的公益合作 伙伴，北大斯坦福亚裔肝脏中心（以下简称"中心"）第五次携手THE COLOR RUN，将专业的健康科普 与大众喜爱的潮流运动结合，通过跨界公益的方式提醒公众关注自身与家人健康、用行动破除偏见、共 同奔向"无乙肝的未来"。 活动现场，在"有爱有益，如何保护小心肝"的翡翠丝带公益互动墙前人潮涌动，众多彩色跑的跑者在摸 高与祝福墙前留下彩色手印，通过趣味抽奖问答了解乙肝的正确知识。本次活动还邀请了众多具备卓越 影响力并对公益事业全力支持的相关组织，包括积极参与中心暑期实践项目的北大爱心社等大学生社 团、关注员工肝脏健康的大型企业，还有佑转德里等热心公益的知名乐队与体校明星等，他们来到中心 ...

Core Viewpoint - The event "Together, Towards a Future Without Hepatitis B" highlights the achievements and ongoing challenges in China's hepatitis B prevention and control efforts over the past 30 years, emphasizing the importance of a collaborative approach involving government, multiple sectors, and society as a whole [1][2]. Group 1: Achievements in Hepatitis B Prevention - China's comprehensive prevention and control work for hepatitis B has shown significant results, with a focus on policy guidance, funding, team building, scientific research, and social security [1]. - The country is at a critical historical juncture in the global goal to eliminate viral hepatitis, with the "Chinese experience" expected to contribute significantly to global health [1]. Group 2: Challenges and Future Goals - Despite progress, challenges remain in achieving the goal of eliminating viral hepatitis by 2030, necessitating a collective effort to address these issues [1]. - There is a need for public health measures to improve the diagnosis and treatment rates of hepatitis B to effectively reduce the incidence of related liver cirrhosis and liver cancer [2]. Group 3: Advances in Treatment - Over the past 30 years, advancements in hepatitis B treatment have led to improved drug efficacy and safety, alongside reduced costs [2]. - The development of new therapies aimed at achieving "functional cure" for hepatitis B is crucial to overcoming the current limitation of long-term treatment for most patients [2].

Core Viewpoint - The article emphasizes the importance of early screening and treatment for chronic hepatitis B virus (HBV) infection to reduce the incidence of liver cirrhosis and liver cancer in China, highlighting the need for public awareness and family involvement in prevention efforts [1][2][3]. Summary by Sections Achievements in Hepatitis B Control - Over the past 30 years, China has made significant progress in controlling viral hepatitis, particularly chronic HBV infection, with the hepatitis B surface antigen positivity rate decreasing from 9.72% in 1992 to 5.86% in 2020, a reduction of over 39% [2]. Risks of Untreated Chronic HBV - Chronic HBV infection is a major cause of liver cirrhosis and liver cancer, with annual incidence rates of 2%-10% for cirrhosis and 3%-6% for liver cancer among untreated patients [2]. - The primary age group affected by chronic HBV infection is between 35 and 55 years, which is critical for family and societal support [2]. Misconceptions About Treatment - There are common misconceptions among the public regarding the necessity of treatment for asymptomatic patients, with a strong emphasis on the need for early antiviral therapy to suppress HBV replication and prevent disease progression [2][3]. - Psychological burdens and stigma associated with HBV infection hinder patients from seeking treatment, with 74% of infected individuals fearing transmission to family members [2]. Recommendations for Prevention and Treatment - It is recommended that adults undergo at least one HBV screening in their lifetime, and those over 30 or with a family history of liver disease should receive antiviral treatment as needed [3][4]. - Family involvement in HBV screening and treatment is crucial for early detection and support, which can help prevent disease progression and improve quality of life [3]. Treatment Accessibility and Innovations - Approximately 95% of chronic HBV infected individuals should be receiving treatment according to current antiviral guidelines, with many effective and safe medications now included in health insurance plans, improving accessibility and affordability [4].